CAITLIN BLAIR: Open Payments
NPI 1073819736 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 14 payments from 7 companies in 2025. Trend: 2023 $428 · 2024 $551 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $307 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Abbott Laboratories | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Wegovy, Ozempic, Rybelsus, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, QULIPTA.
Industry payments across VA — which companies pay providers there.
